Bass AS, Cartwright ME, Mahon C, Morrison R, Snyder R, McNamara P, Bradley P, Zhou YY, Hunter J (2009) Exploratory drug safety: a discovery strategy to reduce attrition in development. J Pharmacol Toxicol Methods 60:69–78. https://doi.org/10.1016/j.vascn.2009.04.194

Article  PubMed  CAS  Google Scholar 

Benjamin B, Barman TK, Chaira T, Paliwal JK (2010) Integration of physicochemical and pharmacokinetic parameters in lead optimization: a physiological pharmacokinetic model based approach. Curr Drug Discov Technol 7:143–153. https://doi.org/10.2174/157016310793180558

Article  PubMed  CAS  Google Scholar 

Berrin JG, McLauchlan WR, Needs P, Williamson G, Puigserver A, Kroon PA, Juge N (2002) Functional expression of human liver cytosolic β-glucosidase in Pichia pastoris. Insights into its role in the metabolism of dietary glucosides. Eur J Biochem 269:249–258. https://doi.org/10.1046/j.0014-2956.2001.02641.x

Article  PubMed  CAS  Google Scholar 

Berrin JG, Czjzek M, Kroon PA, McLauchlan WR, Puigserver A, Williamson G, Juge N (2003) Substrate (aglycone) specificity of human cytosolic beta-glucosidase. Biochem J 373:41–48. https://doi.org/10.1042/BJ20021876

Article  PubMed  PubMed Central  CAS  Google Scholar 

Bijsterbosch MK, Duursma AM, Bouma JM, Gruber M, Nieuwenhuis P (1981) Plasma clearance and endocytosis of mitochondrial malate dehydrogenase in the rat. Biochem J 200:115–121. https://doi.org/10.1042/bj2000115

Article  PubMed  PubMed Central  CAS  Google Scholar 

Boersma MG, van der Woude H, Bogaards J, Boeren S, Vervoort J, Cnubben NH, van Iersel ML, van Bladeren PJ, Rietjens IM (2002) Regioselectivity of phase II metabolism of luteolin and quercetin by UDP-glucuronosyl transferases. Chem Res Toxicol 15:662–670. https://doi.org/10.1021/tx0101705

Article  PubMed  CAS  Google Scholar 

Chawla S, Ghosh S, Sihorkar V, Nellore R, Shantha-Kumar TR, Srinivas NR (2006) High-performance liquid chromatography method development and validation for simultaneous determination of five model compounds, antipyrine, metoprolol, ketoprofen, furosemide and phenol red, as a tool for the standardization of rat in situ intestinal permeability studies using timed wavelength detection. Biomed Chromatogr 20:349–357. https://doi.org/10.1002/bmc.570

Article  PubMed  CAS  Google Scholar 

Courts FL, Williamson G (2009) The C-glycosyl flavonoid, aspalathin, is absorbed, methylated and glucuronidated intact in humans. Mol Nutr Food Res 53:1104–1111. https://doi.org/10.1002/mnfr.200800569

Article  PubMed  CAS  Google Scholar 

Dai P, Luo F, Wang Y, Jiang H, Wang L, Zhang G, Zhu L, Hu M, Wang X, Lu L, Liu Z (2015a) Species- and gender-dependent differences in the glucuronidation of a flavonoid glucoside and its aglycone determined using expressed UGT enzymes and microsomes. Biopharm Drug Dispos 36:622–635. https://doi.org/10.1002/bdd.1989

Article  PubMed  CAS  Google Scholar 

Dai P, Zhu L, Luo F, Lu L, Li Q, Wang L, Wang Y, Wang X, Hu M, Liu Z (2015b) Triple recycling processes impact systemic and local bioavailability of orally administered flavonoids. AAPS J 17:723–736. https://doi.org/10.1208/s12248-015-9732-x

Article  PubMed  PubMed Central  CAS  Google Scholar 

Damle B, LaBadle R, Crownover P, Glue P (2007) Pharmacokinetic interactions of efavirenz and voriconazole in healthy volunteers. Br J Clin Pharmacol 65:523530. https://doi.org/10.1111/j.1365-2125.2007.03085.x

Article  CAS  Google Scholar 

Day AJ, Gee JM, DuPont MS, Johnson IT, Williamson G (2003) Absorption of quercetin-3-glucoside and quercetin-4’-glucoside in the rat small intestine: the role of lactase phlorizin hydrolase and the sodium-dependent glucose transporter. Biochem Pharmacol 65:1199–1206. https://doi.org/10.1016/s0006-2952(03)00039-x

Article  PubMed  CAS  Google Scholar 

Du Y, Xi M, Li Y, Zheng R, Ding X, Li X, Zhang X, Wang L, Xing J, Hong B (2023) Tilianin improves lipid profile and alleviates atherosclerosis in ApoE-/- mice through up-regulation of SREBP2-mediated LDLR expression. Phytomedicine 109:154577. https://doi.org/10.1016/j.phymed.2022.154577

Article  PubMed  CAS  Google Scholar 

Estrada-Reyes R, López-Rubalcava C, Ferreyra-Cruz OA, Dorantes-Barrón AM, Heinze G, Moreno-Aguilar J, Martínez-Vázquez M (2014) Central nervous system effects and chemical composition of two subspecies of Agastache mexicana; an ethnomedicine of Mexico. J Ethnopharmacol 153:98–110. https://doi.org/10.1016/j.jep.2013.12.057

Article  PubMed  CAS  Google Scholar 

Flores-Flores A, Hernández-Abreu O, Rios MY, León-Rivera I, Aguilar-Guadarrama B, Castillo-España P, Perea-Arango I, Estrada-Soto S (2016) Vasorelaxant mode of action of dichloromethane-soluble extract from Agastache mexicana and its main bioactive compounds. Pharm Biol 54:2807–2813. https://doi.org/10.1080/13880209.2016.1184690

Article  PubMed  CAS  Google Scholar 

García-Díaz JA, Navarrete-Vázquez G, García-Jiménez S, Hidalgo-Figueroa S, Almanza-Pérez JC, Alarcón-Aguilar FJ, Gómez-Zamudio J, Cruz M, Ibarra-Barajas M, Estrada-Soto S (2016) Antidiabetic, antihyperlipidemic and anti-inflammatory effects of tilianin in streptozotocin-nicotinamide diabetic rats. Biomed Pharmacother 83:667–675. https://doi.org/10.1016/j.biopha.2016.07.023

Article  PubMed  CAS  Google Scholar 

González-Trujano ME, Ventura-Martínez R, Chávez M, Díaz-Reval I, Pellicer F (2012) Spasmolytic and antinociceptive activities of ursolic acid and acacetin identified in Agastache mexicana. Planta Med 78:793–796. https://doi.org/10.1055/s-0031-1298416

Article  PubMed  CAS  Google Scholar 

González-Trujano ME, Ponce-Muñoz H, Hidalgo-Figueroa S, Navarrete-Vázquez G, Estrada-Soto S (2015) Depressant effects of Agastache mexicana methanol extract and one of major metabolites tilianin. Asian Pac J Trop Med 8:185–190. https://doi.org/10.1016/S1995-7645(14)60312-6

Article  PubMed  Google Scholar 

Guo X, Cao W, Yao J, Yuan Y, Hong Y, Wang X, Xing J (2015) Cardioprotective effects of tilianin in rat myocardial ischemia-reperfusion injury. Mol Med Rep 11:2227–2233. https://doi.org/10.3892/mmr.2014.2954

Article  PubMed  CAS  Google Scholar 

Gupta SC, Sundaram C, Reuter S, Aggarwal BB (2010) Inhibiting NF-κB activation by small molecules as a therapeutic strategy. Biochim Biophys Acta 1799:775–787. https://doi.org/10.1016/j.bbagrm.2010.05.004

Article  PubMed  PubMed Central  CAS  Google Scholar 

Hartmann A, Krebber R, Daube G, Hartmann K (2008) Pharmacokinetics of pradofloxacin and doxycycline in serum, saliva, and tear fluid of cats after oral administration. J Vet Pharmacol Ther 31:87–94. https://doi.org/10.1111/j.1365-2885.2007.00932.x

Article  PubMed  CAS  Google Scholar 

Havsteen BH (2002) The biochemistry and medical significance of the flavonoids. Pharmacol Ther 96:67–202. https://doi.org/10.1016/s0163-7258(02)00298-x

Article  PubMed  CAS  Google Scholar 

Hernández-Abreu O, Castillo-España P, León-Rivera I, Ibarra-Barajas M, Villalobos-Molina R, González-Christen J, Vergara-Galicia J, Estrada-Soto S (2009) Antihypertensive and vasorelaxant effects of tilianin isolated from Agastache mexicana are mediated by NO/cGMP path way and potassium channel opening. Biochem Pharmacol 78:54–61. https://doi.org/10.1016/j.bcp.2009.03.016

Article  PubMed  CAS  Google Scholar 

Hernández-Abreu O, Durán-Gómez L, Best-Brown R, Villalobos-Molina R, Rivera-Leyva JC, Estrada-Soto S (2011) Validated liquid chromatographic method and analysis of content of tilianin on several extracts obtained from Agastache mexicana and its correlation with vasorelaxant effect. J Ethnopharmacol 138:487–491. https://doi.org/10.1016/j.jep.2011.09.041

Article  PubMed  CAS  Google Scholar 

Hernández-Abreu O, Torres-Piedra M, García-Jiménez S, Ibarra-Barajas M, Villalobos-Molina R, Montes S, Rembao D, Estrada-Soto S (2013) Dose-dependent antihypertensive determination and toxicological studies of tilianin isolated from Agastache mexicana. J Ethnopharmacol 146:187–191. https://doi.org/10.1016/j.jep.2012.12.029

Article  PubMed  CAS  Google Scholar 

Hong JJ, Choi JH, Oh SR, Lee HK, Park JH, Lee KY, Kim JJ, Jeong TS, Oh GT (2001) Inhibition of cytokine-induced vascular cell adhesion molecule-1 expression; possible mechanism for anti-atherogenic effect of Agastache rugosa. FEBS Lett 495:142–147. https://doi.org/10.1016/s0014-5793(01)02379-1

Article  PubMed